Genetic variation in human drug-related genes
Abstract Background Variability in drug efficacy and adverse effects are observed in clinical practice. While the extent of genetic variability in classic pharmacokinetic genes is rather well understood, the role of genetic variation in drug targets is typically less studied. Methods Based on 60,706...
المؤلفون الرئيسيون: | Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
BMC
2017-12-01
|
سلاسل: | Genome Medicine |
الموضوعات: | |
الوصول للمادة أونلاين: | http://link.springer.com/article/10.1186/s13073-017-0502-5 |
مواد مشابهة
-
A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort
حسب: Kathrin Klein, وآخرون
منشور في: (2019-01-01) -
Pharmacogenomics-Based Detection of Variants Involved in Pain, Anti-inflammatory and Immunomodulating Agents Pathways by Whole Exome Sequencing and Deep in Silico Investigations Revealed Novel Chemical Carcinogenesis and Cancer Risks
حسب: Alireza Sharafshah, وآخرون
منشور في: (2025-02-01) -
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
حسب: Daniel Felipe Silgado-Guzmán, وآخرون
منشور في: (2022-06-01) -
PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
حسب: N. V. Shcherbakova, وآخرون
منشور في: (2015-09-01) -
Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
حسب: Abdeslam Jaafari, وآخرون
منشور في: (2022-11-01)